Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Olfactory Training For Post Radiation Olfactory Loss In Patients With Paranasal Sinus and Nasopharyngeal Carcinoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03049358
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:00.984187+00:00
Published At
2019-02-05T00:00:00+00:00
Record Updated At
2019-02-05
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Stage 0 Nasopharyngeal Carcinoma", "Stage 0 Paranasal Sinus Cancer", "Stage I Nasopharyngeal Carcinoma", "Stage I Paranasal Sinus Cancer", "Stage II Nasopharyngeal Carcinoma", "Stage II Paranasal Sinus Cancer", "Stage IIA Nasopharyngeal Carcinoma", "Stage IIB Nasopharyngeal Carcinoma", "Stage III Nasopharyngeal Carcinoma", "Stage III Paranasal Sinus Cancer", "Stage IV Nasopharyngeal Carcinoma", "Stage IV Paranasal Sinus Cancer", "Stage IVA Nasopharyngeal Carcinoma", "Stage IVA Paranasal Sinus Cancer", "Stage IVB Nasopharyngeal Carcinoma", "Stage IVB Paranasal Sinus Cancer", "Stage IVC Nasopharyngeal Carcinoma", "Stage IVC Paranasal Sinus Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-02-05"
protocolSection.identificationModule.nctId
"NCT03049358"
protocolSection.identificationModule.officialTitle
"Olfactory Training For Post Radiation Olfactory Loss In Patients With Paranasal Sinus and Nasopharyngeal Carcinoma"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Stage 0 Nasopharyngeal Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage 0 Paranasal Sinus Cancer (protocolSection.conditionsModule.conditions)
  • Stage I Nasopharyngeal Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage I Paranasal Sinus Cancer (protocolSection.conditionsModule.conditions)
  • Stage II Nasopharyngeal Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage II Paranasal Sinus Cancer (protocolSection.conditionsModule.conditions)
  • Stage IIA Nasopharyngeal Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IIB Nasopharyngeal Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Nasopharyngeal Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Paranasal Sinus Cancer (protocolSection.conditionsModule.conditions)
  • Stage IV Nasopharyngeal Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IV Paranasal Sinus Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVA Nasopharyngeal Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IVA Paranasal Sinus Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVB Nasopharyngeal Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IVB Paranasal Sinus Cancer (protocolSection.conditionsModule.conditions)
  • Stage IVC Nasopharyngeal Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IVC Paranasal Sinus Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.